Andrew Booth

Chief Financial Officer, AbCellera Biologics Inc.

Search every verified Andrew Booth interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Andrew Booth, Chief Financial Officer at Abcellera Biologics, participated in the June 2025 episode of Conversations Live with Stuart McNish, focused on the future of British Columbia’s life sciences sector. During the discussion, Booth emphasized the importance of anchor companies in building the industry, citing Stem Cell Technologies as an example of long-term growth that has helped establish confidence for other firms in Canada. He also noted that Canada is the only G7 country without a major pharmaceutical company, framing this as a gap to address. Booth also characterized the current state of biology and biotech as comparable to the position of electronics and semiconductors in the 1950s, describing the sector as presenting a once-in-a-century opportunity for Canada and British Columbia to support its growth into a meaningful part of the economy over the next 50 to 100 years. He discussed Abcellera’s considerations for expanding beyond its current location, including potential sites in the interior of the province near universities, and stressed the need to turn healthcare from a cost center into a revenue generator by building globally competitive biopharma products, noting that only 3% of sales are currently domestic.